BioCryst Pharmaceuticals Inc
BCRX
☕ $6/day into BCRX since 2015 would be worth $25,750 today — 1.5× the money.
Try your own number →BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.
Description from Wikipedia · CC BY-SA 4.0
Read more on Wikipedia →If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of BCRX would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1994) — listing | $87,829 1.8× | $127,438 1.8× |
| Year 6 (1999) | $79,421 1.9× | $115,194 1.9× |
| Year 11 (2004) | $60,106 1.8× | $87,100 1.8× |
| Year 16 (2009) | $47,836 1.8× | $69,370 1.8× |
| Year 21 (2014) | $27,033 1.4× | $39,138 1.4× |
| Year 26 (2019) | $16,004 1.4× | $23,107 1.4× |
| Year 31 (2024) | $4,524 1.3× | $6,604 1.2× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Durham, North Carolina, United States
Popular scenarios with BCRX
For illustration only — not investment advice. Past performance is not indicative of future results.